Polypill Versus Metformin in New Onset Type 2 Diabetes
Condition: Type 2 Diabetes Interventions: Drug: GMRx4 polypill - sitagliptin, dapagliflozin, metformin; Drug: Metformin Sponsors: George Medicines PTY Limited; MRCF Pty Ltd; The George Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Forxiga | Janumet | Januvia | Metformin | Research